HLHS Cause to Cure

Hypoplastic Left Heart Syndrome Program from Mayo Clinic

Share this:
January 24, 2017

Using Regenerative Medicine to Find Answers for Hypoplastic Left Heart Syndrome

By Suzanne Ferguson

The goal of the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is to discover how regenerative medicine, also known as the use of stem cells, can make HLHS hearts bigger, better and stronger in order to delay or even prevent heart failure. In the video below, Dr. Timothy Nelson, director, discusses the HLHS program including a clinical trial for HLHS patients in which umbilical cord blood is collected at birth, processed, and delivered into the heart muscle during one of the patient’s surgeries.

To learn more, contact the program at HLHS@mayo.edu.

 

------------------------------------------------------------------------------------------------------------------------------------
The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies. Contact the program at HLHS@mayo.edu.

 

Tags: CHD, clinical trials, Clinical Trials, Congenital Heart Disease, Dr. Timothy Nelson, HLHS, Hypoplastic Left Heart Syndrome, Mayo Clinic, regenerative medicine, Regenerative Medicine, Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, umbilical cord blood, Umbilical Cord Blood

COMMENT

Please login or register to post a comment.
Contact Us · Privacy Policy